Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc vs Etravirine in HIV/Hepatitis Co-infected Patients
NCT00782301Phase 4Withdrawn
- Sponsor
- ViiV Healthcare
- Start
- Mar 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Planned start Mar 2009; status: withdrawn.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00782301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00782301.